PureCycle Technologies Inc. Common stock (NASDAQ: PCT)
The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: : (i) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (ii) the challenges posed by the availability and competition for the raw materials necessary to commercialize the licensed technology are significant; (iii) PureCycle’s financial projections are baseless; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.